AbbVie (NYSE:ABBV) Updates Q3 2024 Earnings Guidance
AbbVie (NYSE:ABBV – Get Free Report) updated its third quarter 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 2.920-2.960 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of -. AbbVie also updated its FY 2024 guidance to 10.710-10.910 EPS. AbbVie […]
5 Oct 23:41 · The Markets Daily